
Tommy John surgery at a turning point: 'Seat belt' gives hope to MLB's repeat patients
Tommy John surgery at a turning point: 'Seat belt' gives hope to MLB's repeat patients Baseball's infamous elbow surgery is a necessary evil – but surgeons and patients are optimistic about the future.
Show Caption
Hide Caption
Gunnar Henderson talks all things Baltimore Orioles and the upcoming MLB season
Gunnar Henderson stops by to talk about the upcoming season with the Orioles and being on the cover of MLB The Show 25.
Sports Seriously
In another timeline, they'd likely be former Cy Young Award winners, MVPs and strikeout champions pining for what was. World Series champions at one time, shells of themselves in the present.
This spring, though, a handful of elite pitchers will see the radar gun light up as they once expected, a batter overmatched and returning to the dugout, and faith in modern medicine greatly reinforced.
It used to be pitchers undergoing a second repair of their elbow's ulnar collateral ligament faced something of a professional death sentence, that multiple Tommy John surgeries meant hanging on, not dominating.
Yet evidence is increasing that the internal brace procedure, pioneered by orthopedist Jeffrey Dugas and accelerated by Keith Meister, the Dallas-based surgeon to the stars, is not simply shoring up careers but potentially returning pitchers back to their profession's apex.
'Ultimately, I know if this were 20 years ago, I wouldn't have had this surgery and would probably be a lot different pitcher,' Spencer Strider, the Atlanta Braves ace who had his second elbow reconstruction in April 2024, told USA TODAY Sports this spring.
'I'm grateful Dr. Meister and everyone else in the industry are doing the work they're doing.'
Strider pitched in an exhibition game last week, just more than 11 months after Meister repaired a tear in his ulnar collateral ligament and installed an internal brace. His showing strongly suggested he remains anything but ordinary on the mound.
The man who struck out more batters – 483 - in Major League Baseball in 2022-23 cracked 98 mph on the radar gun and struck out six of the eight Boston Red Sox he faced, including five in a row, and could soon begin a rehab assignment and be back on the mound for the Braves within several weeks.
This weekend, Walker Buehler will take the mound for the Boston Red Sox, who were confident enough to pay Buehler $21 million this year in his latest step from a second reconstruction and internal brace insertion in August 2022.
Even as they expect to temper his innings as he approaches his 37th birthday, the Texas Rangers are thrilled two-time Cy Young Award winner Jacob deGrom will make his first turn through their rotation, two years after his procedure with Meister ensured their $180 million investment in him may not be for naught.
And sometime after Strider pitches in a real game, the Dodgers should be welcoming back to the mound Shohei Ohtani, the two-way player who underwent his second elbow reconstruction in five years in 2023.
Make no mistake: Results aren't guaranteed, no outcome preordained, as we learned Saturday when Shane McClanahan, the Tampa Bay Rays' opening day starter and a two-time Tommy John patient, suffered a triceps injury just days before he was to throw their first pitch of 2025.
So it goes for pitchers, who must sidestep dozens of potential maladies even as the constant monster under the bed – a failure of their elbow's ulnar collateral ligament, and the likely reconstructive surgery to follow – lurks.
Yet it's been seven years since Meister deployed the hybrid reconstruction on a patient, creating a personal sample size that now numbers around 500. In that group, nearly 150 underwent their second or even third Tommy John surgery or repair.
The results are still preliminary, but also highly encouraging.
'Of the revisions – meaning second and potentially third Tommy Johns where we put a tendon graft in and a brace – we actually have not had a single ligament re-tear. Which is incredible,' Meister tells USA TODAY Sports. 'They failed in other ways – a couple flexor tendon tears, other things that have broken down. But the weak link in the chain, and I don't think it is any longer, is the ligament itself. I think we've moved the needle.
'Now, time is going to make fools of all of us, as we all know. I don't want to oversell this and say we have a perfect solution to anything. But it's moved the needle in a positive direction with our second – and in some cases third –Tommy John recipients.'
And any positive step forward comes at a time elbow failures, in an era where pitchers thirst for unprecedented pitch velocity and movement, remain the game's greatest scourge.
A second chance – and then a second surgery
Throughout organized baseball, from the travel ball circuits to the stadiums with three decks, there are thousands of athletes, almost all pitchers, whose first Tommy John surgery gave them another shot. In 2023, 35.3% of major league pitchers had undergone Tommy John surgery, a 29% increase from 2016.
With a success rate of around 90%, and roughly 80% of pitchers reaching their prior performance level, the surgery could reliably ensure roughly a decade of elbow health.
Not any longer.
'In 13 years as a GM,' says Braves executive vice president Alex Anthopoulos, 'this is just anecdotal. But they don't seem to last as long.'
He's not wrong. Anthopoulos' club drafted Strider in 2020, when he was still on the way back from 2019 surgery as a Clemson sophomore. Five years later, he was back for another repair.
Ohtani underwent his first Tommy John on Oct. 1, 2018. His second came almost exactly five years later. Buehler went under the knife in August 2015, shortly after the Dodgers drafted him out of Vanderbilt. It lasted him until June 2022.
When New York Mets pitcher Drew Smith first had the procedure in 2019, he was told it should be good for seven to 10 years.
Last July, he was back in the operating room.
'It was shocking for it to only last five years,' says Smith, whom the Mets re-signed to a two-year minor league contract, with hopes he can pitch for them in 2026.
For Meister, that shock has long worn off when he sees old patients back for another round.
The connection between hard throwers and elbow trouble is relatively well-established, even if UCLs can fail for innumerable reasons. Yet in an era where pitchers are able to manipulate baseballs in manners previously unimaginable, it is the stuff – the turbo sinkers that near 100 mph and the power changeups and beguiling sweepers with a foot and a half of horizontal run – that makes Meister shake his head.
'There's absolutely zero question in my mind this is a consequence of velocity and probably even moreso for me now, spin," says Meister. 'What they have to do is squeeze the ball so hard to be able to create that type of spin and ball movement that it puts this undue load on the medial side, the inner side of the elbow, that I think is contributing in a great way to this spike in injuries.
'We have to make changes. Unfortunately, there's been no real motivation in Major League Baseball to make these changes.'
Meister needs no peer-reviewed study on that point.
'As easily fixable you can make (elbow injuries), the better,' says Buehler, who played key roles in the Dodgers' World Series championships in 2020 and 2024.
'But at the end of the day we're all trying to throw hard and get people out and there's risks that come with that. And if you're not willing to take that risk, you probably won't get here the way you want.'
Says Strider: 'Now we've got to start looking into our daily behavior. Not philosophy, not velocity – that's not going away, nor should we want it to.
'But how do we manage workload, how can we be smarter, how can we utilize feedback, both visual and data-driven, to be healthier. That takes time to conduct those experiments and feel good about that process.'
For now, the operating room is the safety net.
'Turning point'
Buehler, 21 at the time of his first Tommy John recovery, called the recovery 'easy breezy" and came back throwing harder than before. He says his second rehab was 'a little more of a struggle,' in part because other injuries – including a mild shoulder malady that upended his chances to return in 2023 – set him back.
He's also a prime example of the pre-surgery uncertainty before doctors get an internal view of the elbow.
Buehler, whose surgery was performed by Los Angeles orthopedist Neal ElAttrache, required both an additional ligament replacement and a flexor tendon repair. ElAttrache also installed the internal brace.
That verdict – be it a new UCL, a repair or revision of the old one, and any other unforeseen damage – will frame how long second-time Tommy John patients must sit out.
Strider may make it back within just more than 12 months, since he required only a revision. Preserving a compromised ligament, rather than replacing it, is a game-changer for pitcher recovery.
'They told me my graft was coming out of the anchor in a very similar spot to my first reconstruction,' says Baltimore Orioles right-hander Tyler Wells, who underwent a revision of his original Tommy John surgery in June and hopes for a midseason return this year. 'My UCL, in a sense, was torn, but it was creating some laxity because it was starting to pull out of the graft.
'They needed to go in there and reattach everything to it, but in that process decided they were going to add the internal brace for additional support. I don't have to go through the same process of ligamentization, where they're putting in the new graft and get it all stretched out. Mine's already like that. That, in turn, makes this kind of rehab a little bit easier than doing the second, full reconstruction.'
And now, Wells' UCL has a brace, which Meister says acts 'as a seat belt, so to speak, on the inner side of the elbow. But I also think there's probably a biologic component to it. I think it's, maybe, enhancing the healing response.'
McClanahan hadn't yet begun his collegiate career at South Florida when he underwent Tommy John surgery. Now, a decade and two All-Star appearances later, he's startled at the advancements in surgery and rehab.
'I was 17 when I had my first one. I'm 27 now," he says. 'I was a kid when it happened. It felt like a different lifetime ago. I feel good, and that's what matters to me.'
Wells, whose mother is a doctor, agrees. He's had enough conversations with Meister, physical therapists and other medical personnel to recognize the evolution has reached a key stage.
'It seems like this is a really big turning point in Tommy John reconstructions or revisions,' he says. 'There's definitely huge progress. That will stabilize a little bit. And eventually you see that next go-round where you take another turn for the better.'
Until then, there will be frustrating steps backward between the progress. McClanahan provided a scare Saturday, when he threw a pitch, hopped in pain and walked off the mound in his final Grapefruit League start.
Turns out it was a triceps, not an elbow injury.
So it goes for pitchers who might throw up to 3,000 pitches this coming season – along with the orthopedists who mend them when their most important ligament fails.
Meister is often joined by other surgeons in his operating room, from as far away as South Korea and Japan, as the industry collaborates to produce something resembling a permanent fix. And after surgery, rehab and the athlete's climb back to active duty, his lab becomes the thousands of mounds across the sport.
For all the advancements that help patients light up a radar gun no matter how many times their elbow has blown, progress, for him, will look like a lunch break uninterrupted by a phone call with another arm needing an MRI, or a waiting room not bursting with return clients.
'Let's get through a season and I can start to feel better about it,' he says. 'Look, it's exciting stuff. On the one hand, I am excited to watch it.
'On the other hand, I'm on pins and needles.'
The USA TODAY app gets you to the heart of the news — fast. Download for award-winning coverage, crosswords, audio storytelling, the eNewspaper and more.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
40 minutes ago
- Yahoo
‘Game-changer' new blood test to detect prevalent autoimmune disease without nightmare side effects
People with coeliac disease may soon be able to avoid consuming large quantities of gluten – the substance that triggers their symptoms – to get a diagnosis. New clinical research published in the journal Gastroenterology has shown a 'game-changer' blood test for gluten-specific T cells that can detect coeliac disease – even when no gluten has been consumed. Currently, people with suspected coeliac are required to eat large amounts of gluten for weeks to get an accurate diagnosis. However, researchers said the new blood test could boost rates of diagnosis, identify patients at risk of severe reactions to gluten and detect silent coeliac disease in asymptomatic people. Coeliac disease is an autoimmune condition where the body attacks its own tissues when gluten is eaten, which prevents normal digestion and absorption of food, with the risk of developing serious health complications. It is driven by eating gluten, a protein found in wheat, barley and rye. An estimated 1 in 100 people have it in the UK. However, only 36 per cent with the condition are clinically diagnosed, according to Coeliac UK. Undiagnosed or untreated coeliac disease can result in complications such as osteoporosis, unexplained infertility, neurological dysfunction and, in rare instances, small bowel cancer, Coeliac UK says. Currently, all coeliac testing methods require regular gluten consumption to be effective, the researchers said. Many people are deterred from seeking a definite diagnosis because they do not want to consume gluten and be sick, the Australia-based scientists added. Associate Professor Jason Tye-Din, Head of WEHI's Coeliac Research Laboratory and a gastroenterologist at the Royal Melbourne Hospital, said: 'There are likely millions of people around the world living with undiagnosed coeliac disease simply because the path to diagnosis is difficult, and at times, debilitating.' 'By eliminating the need for a gluten challenge, we're addressing one of the biggest deterrents in current diagnostic practices,' she added. 'This test could be a game-changer, sparing thousands of people the emotional and physical toll of returning to gluten. It's a major step towards faster, safer diagnosis.' The study evaluated the potential of a blood test to measure an immune marker interleukin 2 (IL-2). In 2019, researchers found this immune marker spiked in the bloodstream of people with coeliac disease shortly after they ate gluten. The scientists used blood samples from 181 volunteers, including 75 people with treated coeliac disease, 13 with active, untreated coeliac disease, 32 people with non-coeliac gluten sensitivity and 61 healthy people. Participant blood samples were then mixed with gluten in a test tube for a day to see if the IL-2 signal appeared. The team was 'thrilled' to find the test could detect the condition with up to 90 per cent sensitivity and 97 per cent specificity – even in patients following a strict gluten-free diet, PhD researcher Olivia Moscatelli, who was diagnosed with coeliac disease at 18, said. The IL-2 signal only increased in the volunteers with coeliac disease, showing the immune response to gluten can be detected in a tube, without the need to consume gluten, researchers said. Ms Moscatelli said the test also performed exceptionally well in people with coeliac disease who had other autoimmune conditions, such as type 1 diabetes or Hashimoto's thyroiditis. The Walter and Eliza Hall Institute team are now collaborating with Novoviah Pharmaceuticals to confirm the test's accuracy across diverse populations and find real-world data.


Associated Press
an hour ago
- Associated Press
Astros play the White Sox with series tied 1-1
Chicago White Sox (23-45, fifth in the AL Central) vs. Houston Astros (37-30, first in the AL West) Houston; Thursday, 8:10 p.m. EDT PITCHING PROBABLES: White Sox: Davis Martin (2-6, 3.62 ERA, 1.21 WHIP, 48 strikeouts); Astros: Framber Valdez (6-4, 3.07 ERA, 1.06 WHIP, 84 strikeouts) BETMGM SPORTSBOOK LINE: Astros -263, White Sox +213; over/under is 7 1/2 runs BOTTOM LINE: The Houston Astros and Chicago White Sox meet on Thursday with the three-game series tied 1-1. Houston has a 37-30 record overall and a 23-13 record at home. The Astros have a 17-26 record in games when they have given up a home run. Chicago is 7-27 on the road and 23-45 overall. The White Sox have a 16-9 record in games when they out-hit their opponents. Thursday's game is the sixth time these teams square off this season. The White Sox hold a 3-2 advantage in the season series. TOP PERFORMERS: Isaac Paredes leads the Astros with 14 home runs while slugging .468. Jeremy Pena is 18 for 41 with five doubles, two home runs and six RBIs over the last 10 games. Andrew Benintendi has seven doubles, a triple, six home runs and 23 RBIs for the White Sox. Mike Tauchman is 6 for 34 with two doubles, a triple and two home runs over the past 10 games. LAST 10 GAMES: Astros: 6-4, .246 batting average, 3.54 ERA, outscored opponents by two runs White Sox: 5-5, .227 batting average, 4.65 ERA, outscored by six runs INJURIES: Astros: Chas McCormick: 10-Day IL (oblique), Ronel Blanco: 60-Day IL (elbow), Zach Dezenzo: 10-Day IL (hand), Hayden Wesneski: 60-Day IL (elbow), Yordan Alvarez: 10-Day IL (hand), Spencer Arrighetti: 15-Day IL (thumb), Luis Garcia: 60-Day IL (elbow), Cristian Javier: 60-Day IL (elbow), J.P. France: 60-Day IL (shoulder), Taylor Trammell: 10-Day IL (calf), Pedro Leon: 10-Day IL (knee) White Sox: Jared Shuster: 15-Day IL (hand), Fraser Ellard: 60-Day IL (lat), Ky Bush: 60-Day IL (elbow), Lenyn Sosa: 10-Day IL (hip), Miguel Castro: 60-Day IL (knee), Jonathan Cannon: 15-Day IL (back), Tyler Gilbert: 15-Day IL (knee), Martin Perez: 60-Day IL (forearm), Drew Thorpe: 60-Day IL (elbow), Prelander Berroa: 60-Day IL (elbow), Jesse Scholtens: 60-Day IL (elbow) ___ The Associated Press created this story using technology provided by Data Skrive and data from Sportradar.


Associated Press
an hour ago
- Associated Press
Orioles and Tigers play in series rubber match
Detroit Tigers (44-25, first in the AL Central) vs. Baltimore Orioles (27-39, fifth in the AL East) Baltimore; Thursday, 6:35 p.m. EDT PITCHING PROBABLES: Tigers: Tarik Skubal (6-2, 2.16 ERA, 0.82 WHIP, 105 strikeouts); Orioles: Dean Kremer (5-6, 4.98 ERA, 1.41 WHIP, 53 strikeouts) BETMGM SPORTSBOOK LINE: Tigers -183, Orioles +151; over/under is 8 runs BOTTOM LINE: Both the Baltimore Orioles and the Detroit Tigers are looking for a series win with a victory on Thursday. Baltimore has gone 13-18 at home and 27-39 overall. Orioles hitters have a collective .392 slugging percentage to rank eighth in the AL. Detroit has a 44-25 record overall and a 21-16 record on the road. The Tigers have the fourth-ranked team slugging percentage in the AL at .406. Thursday's game is the sixth time these teams meet this season. The Tigers are up 4-1 in the season series. TOP PERFORMERS: Ryan O'Hearn has eight doubles and nine home runs while hitting .308 for the Orioles. Adley Rutschman is 13 for 38 with two doubles and two home runs over the past 10 games. Spencer Torkelson has 15 doubles and 16 home runs for the Tigers. Riley Greene is 13 for 37 with three doubles and four RBIs over the past 10 games. LAST 10 GAMES: Orioles: 7-3, .258 batting average, 2.86 ERA, outscored opponents by 14 runs Tigers: 6-4, .255 batting average, 3.47 ERA, even run differential INJURIES: Orioles: Jorge Mateo: 10-Day IL (elbow), Ryan Mountcastle: 10-Day IL (hamstring), Cody Poteet: 60-Day IL (shoulder), Tyler O'Neill: 10-Day IL (shoulder), Grayson Rodriguez: 60-Day IL (elbow), Gary Sanchez: 10-Day IL (wrist), Albert Suarez: 60-Day IL (shoulder), Tyler Wells: 60-Day IL (elbow), Kyle Bradish: 60-Day IL (elbow) Tigers: Jason Foley: 60-Day IL (shoulder), Alex Cobb: 60-Day IL (hip), Jackson Jobe: 15-Day IL (flexor), Matt Vierling: 10-Day IL (shoulder), Reese Olson: 15-Day IL (finger), Ty Madden: 60-Day IL (shoulder), Jose Urquidy: 60-Day IL (elbow), Alex Lange: 60-Day IL (lat) ___ The Associated Press created this story using technology provided by Data Skrive and data from Sportradar.